- Home
- MRNA vs CART Comparison
MRNA vs CART Comparison
Compare MRNA & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- CART
- Stock Information
- Founded
- MRNA 2010
- CART 2012
- Country
- MRNA United States
- CART United States
- Employees
- MRNA N/A
- CART N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- CART
- Sector
- MRNA Health Care
- CART
- Exchange
- MRNA Nasdaq
- CART Nasdaq
- Market Cap
- MRNA 9.2B
- CART 12.2B
- IPO Year
- MRNA 2018
- CART 2023
- Fundamental
- Price
- MRNA $24.45
- CART $36.75
- Analyst Decision
- MRNA Hold
- CART Buy
- Analyst Count
- MRNA 15
- CART 26
- Target Price
- MRNA $36.69
- CART $53.46
- AVG Volume (30 Days)
- MRNA 11.9M
- CART 5.3M
- Earning Date
- MRNA 11-06-2025
- CART 11-10-2025
- Dividend Yield
- MRNA N/A
- CART N/A
- EPS Growth
- MRNA N/A
- CART N/A
- EPS
- MRNA N/A
- CART 1.73
- Revenue
- MRNA $2,232,000,000.00
- CART $3,546,000,000.00
- Revenue This Year
- MRNA N/A
- CART $12.29
- Revenue Next Year
- MRNA $10.38
- CART $9.57
- P/E Ratio
- MRNA N/A
- CART $21.23
- Revenue Growth
- MRNA N/A
- CART 10.47
- 52 Week Low
- MRNA $23.04
- CART $34.78
- 52 Week High
- MRNA $56.70
- CART $53.50
- Technical
- Relative Strength Index (RSI)
- MRNA 43.91
- CART 41.25
- Support Level
- MRNA $23.48
- CART $34.78
- Resistance Level
- MRNA $25.56
- CART $37.79
- Average True Range (ATR)
- MRNA 1.49
- CART 1.23
- MACD
- MRNA -0.32
- CART -0.06
- Stochastic Oscillator
- MRNA 22.89
- CART 38.63
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CART Maplebear Inc.
Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.